Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Argininosuccinate synthetase 1 pseudogene 3 (ASS1P3) is a non-functional genomic pseudogene found in humans. Unlike the active ASS1 gene, which encodes the enzyme argininosuccinate synthetase 1 involved in the urea cycle and arginine biosynthesis, ASS1P3 does not produce a functional protein, and its sequence is considered a genetic relic without demonstrated biological function or therapeutic relevance. The presence of multiple pseudogenes related to ASS1 reflects natural genetic duplication and evolutionary processes, but these copies, including ASS1P3, do not impact metabolic function or serve as therapeutic targets[4]. If you intended to request information on "Argininosuccinate synthetase 1" (ASS1), that is a valid therapeutic enzyme/receptor, but ASS1P3 as a pseudogene is not[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Argininosuccinate synthetase 1 pseudogene 3 (ASS1P3).